Clinical Trial Update: Pharmacokinetic Study of a Single Dose of AVI-4065 in Cerebral Spinal Fluid [Phase 1]

View source ↗

Summary

A Phase 1 pharmacokinetic study evaluating a single dose of AVI-4065 in cerebrospinal fluid has completed in participants with encephalitis. The trial assessed …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Encephalitis

Drugs mentioned

• AVI-4065

Snippet

Sponsor: Sarepta Therapeutics, Inc. | Conditions: Encephalitis | Phase 1 | Status: COMPLETED